Lawyers Alert Victims: Bayer Still Settling Yaz Lawsuits

Monday, March 24, 2014

Women who’ve taken the birth control pills Yaz, Yasmin, Ocella or Gianvi were alerted to a new safety warning last month when the U.K.’s Medicines and Healthcare Products Regulatory Agency advised the drugs could cause blood clots.

This follows years of warnings about Yaz blood clots from experts around the world including the FDA, Health Canada, European Medicines Agency and New England Journal of Medicine.

However, what many victims don’t know is that Bayer, the company that makes Yaz, is continuing to pay billions in settlements to those injured.

In fact, FDA records show more than 20,000 women have suffered blood clot-type injuries while using Yaz or Yasmin, but only half of those have filed lawsuits.

So many have joined the legal action that a special federal court was created to expedite the process. Instead of facing trial, Bayer agreed to compensate those who suffered blood clots, pulmonary embolism, deep vein thrombosis and some strokes.

In their last financial report, Bayer admitted they’ve spent almost $1.7 billion already to settle around 8,250 of these cases, at an average of more than $200,000 per victim.

They also said they’ll continue to review claims from those injured.

Lawyers say in most cases, women had to have suffered a blood clot, DVT, pulmonary embolism or stroke while taking Yaz or a similar drug prior to mid-2012, when label warnings were added. Some injuries occurring after they stopped taking the drug, or from generic versions will also be considered.

Bayer has compensated victims who suffered blood clots more than 10 years ago. However, lawyers warn that time is running out to file a claim.

Blood clots can cause serious injury if they block blood and oxygen to the legs (deep vein thrombosis), the brain (stroke) or the lungs (pulmonary embolism). In most cases victims are hospitalized and have to undergo long-term medical treatment.

Authored by Chris Schroeder

birth control

Other drugs and devices in the news:

Tuesday, April 14, 2020
Sudden Rise in Elmiron Eye Disease Cases Raises Questions

Elmiron is a mild blood-thinner drug that has been around since 1996 and is prescribed to treat bladder pain or inflammation, a condition called interstitial cystitis.

Monday, April 13, 2020
Asbestos Mesothelioma
Estimated $30 Billion Left Unclaimed in Asbestos Victim Funds

Since many of the companies that sold asbestos or used it in their products have long since gone out of business, people who are diagnosed with asbestos-related cancers often think it’s too late to file a lawsuit.

Get in touch with us.

Call, email or live chat with us today to see how we can help.

Need a quick answer? Call us!
Reach out to us by email.
live chat with DrugNews
We are here to help now